Age at diagnosis is an important prognostic factor in Philadelphia-negative Myeloproliferative Neoplasms

Eur J Haematol. 2019 Aug;103(2):140-141. doi: 10.1111/ejh.13266. Epub 2019 Jun 13.

Authors

Vincenzo Accurso¹, Marco Santoro², Sergio Siragusa¹

Affiliations

¹ Hematology Division, University Hospital Policlinico "Paolo Giaccone", Palermo, Italy.
² Department of Surgical, Oncological and Stomatological Disciplines, University of Palermo, Palermo, Italy.

PMID: 31121064
DOI: 10.1111/ejh.13266

No abstract available

Publication types

Letter

MeSH terms

Age Factors
Age of Onset
Biomarkers, Tumor
Humans
Myeloproliferative Disorders / diagnosis
Myeloproliferative Disorders / epidemiology
Myeloproliferative Disorders / genetics*
Myeloproliferative Disorders / mortality*
Philadelphia Chromosome*
Prognosis

Substances

Biomarkers, Tumor